| |
| |
|
| Insider
Information: |
Yancopoulos George |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
801,608 |
|
|
Indirect Shares
|
465,370 |
|
|
| Direct
Value |
$707,980,186 |
|
|
|
Indirect Value
|
$411,014,784 |
|
|
| Total
Shares |
1,266,978 |
|
|
| Total
Value |
$1,118,994,970 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-02-15 |
801,608 |
2024-02-15 |
465,370 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2024-02-15 |
4 |
OE |
$399.66 |
$69,030,474 |
D/D |
172,723 |
925,209 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2024-02-15 |
4 |
D |
$953.83 |
$117,894,342 |
D/D |
(123,601) |
801,608 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2024-01-02 |
4 |
AS |
$900.00 |
$15,163,200 |
I/I |
(16,848) |
180,000 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2023-12-11 |
4 |
D |
$844.09 |
$10,838,960 |
D/D |
(12,841) |
752,486 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2023-12-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,155 |
765,327 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2023-03-23 |
4 |
AS |
$800.59 |
$2,940,374 |
I/I |
(3,656) |
196,848 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2023-02-06 |
4 |
AS |
$800.08 |
$10,552,255 |
I/I |
(13,189) |
200,504 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-12-22 |
4 |
OE |
$179.13 |
$97,775,813 |
D/D |
442,267 |
1,169,835 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-12-22 |
4 |
D |
$610.04 |
$189,171,574 |
D/D |
(310,097) |
1,019,653 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-08-16 |
4 |
AS |
$625.25 |
$30,781,138 |
D/D |
(49,227) |
887,483 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-08-13 |
4 |
AS |
$625.00 |
$483,125 |
D/D |
(773) |
936,710 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-08-05 |
4 |
AS |
$600.06 |
$30,003,000 |
D/D |
(50,000) |
937,483 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-06-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
211,585 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-06-24 |
4 |
GA |
$0.00 |
$0 |
I/I |
211,585 |
213,693 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-06-21 |
4 |
AS |
$532.89 |
$43,112,141 |
I/I |
(80,000) |
2,108 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-01-12 |
4 |
GA |
$0.00 |
$0 |
I/I |
82,108 |
82,108 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-12-30 |
4 |
D |
$483.25 |
$104,773,433 |
D/D |
(216,810) |
822,207 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-12-30 |
4 |
OE |
$52.03 |
$20,712,050 |
D/D |
398,079 |
908,303 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-07-27 |
4 |
GD |
$0.00 |
$0 |
I/I |
57,465 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-03-10 |
4 |
AS |
$461.79 |
$55,428,041 |
D/D |
(117,815) |
517,799 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-03-09 |
4 |
OE |
$30.63 |
$7,557,524 |
D/D |
246,736 |
713,990 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-03-09 |
4 |
D |
$476.42 |
$61,420,543 |
D/D |
(128,921) |
635,614 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-02-24 |
4 |
AS |
$420.17 |
$49,631,741 |
D/D |
(118,123) |
517,799 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-12-12 |
4 |
OE |
$21.25 |
$5,212,519 |
D/D |
245,295 |
521,876 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-12-12 |
4 |
D |
$377.16 |
$47,964,192 |
D/D |
(127,172) |
444,109 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
